ProPhase Labs, Inc. ( PRPH) - Stock Earnings
PRPH Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -6.8 million USD | 883000 USD |
| 2025Q4 | -7.4 million USD | 784000 USD |
| 2026Q1 | -7.4 million USD | 784000 USD |
PRPH Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -16.8 million USD | 44.4 million USD |
| 2024 | -53.4 million USD | 6.8 million USD |
| 2025 | -14.7 million USD | 4.3 million USD |
| 2026 Est. | — | — |
PRPH
Price: $0.06
52 week price:
Payout Ratio Range:
Earnings Per Share: -2.75 USD
Exchange: NCM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 65100
Ebitda: -2.3 millionMarket Capitalization: 342486
Average Dividend Frequency: 1